8-K current report · filed Jul 2, 2026

AVANOS MEDICAL, INC. (AVNS) 8-K Current Report: July 2, 2026

Item EX-99.1Item 7.01AVNS overview

Short answer

AVANOS MEDICAL, INC. (AVNS) filed an 8-K current report with the SEC on July 2, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). All required regulatory approvals received for Avanos acquisition by American Industrial Partners affiliates.

AVANOS MEDICAL, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • All required regulatory approvals received for Avanos acquisition by American Industrial Partners affiliates
  • Transaction now cleared to complete, reducing regulatory closing uncertainty
  • Acquisition outcome becomes primary near-term catalyst for Avanos shareholders

Item EX-99.1 · Exhibit EX-99.1

  • All required regulatory approvals received, removing a major condition for AIP’s pending acquisition of Avanos
  • Stockholder vote scheduled July 22, 2026, at 9:00 a.m. Eastern time
  • Transaction expected to close by July 27, 2026, subject to stockholder approval and remaining customary conditions
  • Key remaining risks include unmet closing conditions, competing proposals, or potential termination fees

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other AVANOS MEDICAL, INC. 8-K filings

Get the next AVNS 8-K as it lands

Follow AVNS for push alerts, or ask the research agent what this filing means.